Global Drug Eluting Balloon Catheters Market Research Report 2022

Drug-eluting balloon catheter is used in undertaking peripheral artery procedures, particularly to reduce the rate of restenosis. A drug-eluting balloon catheter is inserted into a narrowed, unhealthy coronary or peripheral artery that slowly releases a drug to restrict further cell proliferation.
Due to the COVID-19 pandemic, the global Drug Eluting Balloon Catheters market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Drug Eluting Balloon Catheters market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Drug Eluting Balloon Catheters landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Polyurethane accounting for % of the Drug Eluting Balloon Catheters global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Drug Eluting Balloon Catheters include Medtronic, Boston Scientific, Terumo, Abbott Laboratories, B. Braun Melsungen, Cardinal Health (Cordis), MicroPort Scientific, Cook Medical and Meril Life Sciences, etc. In terms of revenue, the global 3 largest players have a % market share of Drug Eluting Balloon Catheters in 2021.
This report focuses on Drug Eluting Balloon Catheters volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Drug Eluting Balloon Catheters market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Drug Eluting Balloon Catheters Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Polyurethane
Nylon
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Boston Scientific
Terumo
Abbott Laboratories
B. Braun Melsungen
Cardinal Health (Cordis)
MicroPort Scientific
Cook Medical
Meril Life Sciences
Hexacath
QX Medical
Biotronik
Tokai Medical